Nov 12, 2019 / 03:00PM GMT
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research Analyst
So good morning. Thanks, everyone, for joining us. My name is Matt Miksic, medical device analyst here at Crédit Suisse. Very pleased to have with us Susie Lisa, Director of Investor Relations, Boston Scientific.
Questions and Answers:
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research AnalystSo we'll jump right into questions. There's a number of topics we can cover obviously but I wanted to maybe start with -- the natural thing would be to start with some of the headwinds that came up ahead of the third quarter and how they played out or how you think that they'll play out or how to quantify them. I know the mic here is a little bit noisy. But I'd like to start instead with maybe some of the key highlights from Q3, where you saw areas of momentum, where you saw areas of strength and maybe as we turn the corner into 2020, where you see some of the most significant growth drivers that